Notice is hereby given to the shareholders of Qlucore AB (publ) (Registration number 556719-3528) that the Annual General Meeting will take place on Wednesday, September 9, 2026, at 15.00 at the company’s office in Lund. Registration starts at 14.45.
Right to participate in the Annual General Meeting and notice of participation
A shareholder who wishes to participate in the Annual General Meeting must be recorded in the share register maintained by Euroclear Sweden AB on Tuesday, September 1, 2026, and report their participation no later than Thursday, September 3, 2026, to info@qlucore.com.
Nominee-registered shares
In addition to providing notification of participation as described above, a shareholder whose shares are held in the name of a nominee must register its shares in its own name so that the shareholder is recorded in the share register relating to the circumstances on September 1, 2026. The registration may be temporary (so-called voting right registration) and is requested from the nominee in accordance with the nominee’s procedures. This means that the shareholder must notify the nominee in ample time. A voting right registration completed no later than the second banking day after September 1, 2026, is considered when preparing the register of shareholders.
Proxy
If shareholders vote by proxy, a written and dated power of attorney signed by the shareholder must be presented by the proxy. If the power of attorney is issued by a legal entity a copy of the registration certificate or equivalent for the legal entity must also be attached. Power of attorney may be valid for a maximum of one year from issuance. Power of attorney and/or proof of registration must be sent to the company at the address below no later than Wednesday, September 3, 2026. Power of attorney forms are available upon request.
Address: Qlucore AB, Scheelevägen 17, 223 70 Lund.
-------------------------------------------------------------------------------------------------------------------
Proposed agenda
1. Opening of the Annual General Meeting and election of Chairman for the Annual General Meeting
2. Preparation and approval of the voting register
3. Election of one or two persons to attest the minutes
4. Determination whether the Annual General Meeting has been duly convened
5. Approval of the agenda for the Annual General Meeting
6. Statement of the CEO
7. Presentation of the annual report and the Auditor’s report, as well as the consolidated annual report and the Auditor’s report for the group
8. Resolution on
a) the adoption of the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet;
b) allocation of the company’s profit according to the adopted balance sheet; and
c) discharge from liability for members of the Board of Directors and the CEO
9. Determination of compensation to the Board of Directors and the Auditors
10. Election of members of the Board of Directors and Auditors
11. Election of members to the election committee
12. Resolution on authorization to issue shares
13. Other
14. Closing of the Annual General Meeting
Proposed resolutions
Item 1 – Opening of the Annual General Meeting and election of Chairman for the Annual General Meeting
The Nomination Committee proposes that the Chairman of the Board of Directors, Lars Pålsson, is appointed Chairman of the 2026 Annual General Meeting.
Item 7b) – Allocation of the company’s profit according to the adopted balance sheet
The board of Directors proposes that the Company's results be carried forward.
Item 8 – Determination of compensation to the Board of Directors and the Auditors
The Nomination Committee proposes that no board fees be paid. The Nomination Committee proposes that the Auditor's fee be paid according to an approved invoice.
Item 9 – Election of members of the Board of Directors and Auditors
The Nomination Committee proposes, for the period until the end of the next Annual General Meeting, the re-election of board members Lars Pålsson (as Chairman), Carl Palmstierna och Kjell Sjöström.
The Nomination Committee proposes re-election of the auditing company PWC for the period until the end of the next Annual General Meeting.
Item 10 – Election of members to the Nomination Committee
The Nomination Committee proposes that the Annual General Meeting instructs the Chairman of the board to contact the four largest registered shareholders based on shareholder statistics as of December 31, 2026, each of whom is offered to appoint a member to form a Nomination Committee together with the Chairman of the board for the period until a new Nomination Committee is appointed according to the mandate from the next annual general meeting.
If the Chairman of the board, directly or through the company, should be one of the four largest shareholders, the Nomination Committee shall consist of the Chairman of the board and the three members appointed by the other three largest shareholders. Where one or more shareholders refrain from appointing a member of the Nomination Committee, one or more of the next three shareholders in ownership must be offered to appoint a member of the Nomination Committee. The Chairman of the Nomination Committee shall be the member appointed by the owner with the largest number of votes, unless the members agree otherwise.
Prior to the Annual General Meeting, the nomination committee consisted of Lars Pålsson, Carl Palmstierna (chairman), Daniel Nilsson och Johan Råde.
Item 12 – Resolution on authorization to issue shares
The board of directors proposes that the general meeting authorize the board of directors, on one or more occasions until the next annual general meeting, to resolve on issues of shares and/or warrants and/or convertible instruments, within the limits of the articles of association, with or without deviation from the shareholders’ preferential rights. Payment may be made in cash, in kind or by way of set-off, and is subject to terms and conditions pursuant to the Swedish Companies Act.
To the extent the authorization is used for issues with deviation from the shareholders’ preferential rights, the subscription price shall be on market terms (subject to market-based issue discounts, where applicable).
The purpose of the authorization and the reasons for any deviation from the shareholders’ preferential rights are to increase the Company’s financial flexibility in connection with specific events, reduce the Company’s debt burden, enable acquisitions, attract new shareholders of strategic importance to the Company, and provide working capital.
The CEO is proposed to be authorized to make such minor adjustments to this resolution as may be necessary in connection with its registration with the Swedish Companies Registration Office and with Euroclear Sweden AB.
Majority requirements
Resolutions under item 12 above require the approval of at least two-thirds of both the votes cast and the shares represented at the general meeting.
Requests for information
The Board of Directors and the CEO shall, if any shareholder so requests and if the Board of Directors considers that this is possible without significant harm to the company, give information on circumstances that may affect the assessment of an item on the agenda, circumstances that may affect the assessment of the financial situation of the company or its subsidiaries and the company’s relationship with another group company.
Availability of documents
The Annual report, auditor's report and complete proposals for resolutions as well as other documents in accordance with the Swedish Companies Act (2005:551) will be made available at the Company's office at the address Ideon Science Park, Scheelevägen 17, 223 70 Lund no later than two weeks before the meeting, i.e., no later than August 26, 2026. The documents will also be sent free of charge to shareholders who have requested them and who have provided their postal address. The documents will also be available at the Annual General Meeting.
Processing of personal data
In connection with the general meeting, personal data will be processed in accordance with the Company’s privacy policy, which is available at:
www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf.
Lund, August 2026
Qlucore AB
The Board of Directors
About Qlucore
Qlucore develops AI‑based software that enables more accurate diagnostics and a more cost‑efficient healthcare system. Through the company’s precision medicine solutions, tens of thousands of genetic data points are transformed into clear decision‑making support, making it possible to deliver the right treatment to each patient at the right time.
The first diagnostic test – for pediatric blood cancer – has been approved for sale within the EU. Additional tests, including for lung cancer, adult blood cancer, and bladder cancer, are under development. These products target large and growing markets with significant medical and economic needs. The goal is to improve treatment outcomes, reduce human suffering, and lower healthcare costs.
In addition to its diagnostics portfolio, Qlucore offers Qlucore Omics Explorer, an established software platform for advanced data analysis used by researchers and pharmaceutical companies worldwide. The company has customers in about 20 countries, sales offices in Europe and North America, and distributors across several Asian markets.
Qlucore is listed on Nasdaq First North Growth market. More information: www.qlucore.com